A gene expression network analysis of the pancreatic islets from lean and obese mice identifies complement 1q like-3 secreted protein as a regulator of β-cell function secreted proteins are important metabolic regulators. Identifying and characterizing the role of secreted proteins from small tissue depots such as islets of Langerhans, which are required for the proper control of whole-body energy metabolism, remains challenging. Our objective was to identify islet-derived secreted proteins that affect islet function in obesity. Lean and obese mouse islet expression data were analyzed by weighted gene co-expression network analysis (WGCNA) to identify trait-associated modules. Subsequently, genes within these modules were filtered for transcripts that encode for secreted proteins based on intramodular connectivity, module membership, and differential expression. Complement 1q like-3 (C1ql3) secreted protein was identified as a hub gene affecting islet function in obesity. Co-expression network, hierarchal clustering, and gene-ontology based approaches identified a putative role for C1ql3 in regulating β-cell insulin secretion. Biological validation shows that C1ql3 is expressed in β-cells, it inhibits insulin secretion and key genes that are involved in β-cell function. Moreover, the increased expression of C1ql3 is correlated with the reduced insulin secretion in islets of obese mice. Herein, we demonstrate a streamlined approach to effectively screen and determine the function of secreted proteins in islets, and identified C1ql3 as a putative contributor to reduced insulin secretion in obesity, linking C1ql3 to an increased susceptibility to type 2 diabetes.
. Gene dendrogram showing co-expression modules in the pancreatic islets of lean and obese mice. Hierarchical clustering was performed for the merged lean and obese islet expression data (N samples = 40 and N Genes = 40639). The branches in the dendrogram denote a cluster of genes. Clusters of highly co-expressed genes are represented as color-coded modules (N modules = 28) shown along the horizontal x-axis. The turquoise module was identified as the major gene cluster (N Genes = 11682), and the grey module represents unassigned genes. The vertical y-axis shows the co-expression distance between genes identified in the dendrogram.
Identification of intramodular connectivity (IMC) and module membership (MM) for genes
within the enriched modules. The IMC was calculated to determine how well a gene is connected with the other genes in the enriched modules (k Total ). We also calculated module membership (MM) to determine how well the expression of each gene is correlated with the 'module-eigengene value, ' calculated by performing a principal component analysis for each module. A total of 15823 unique genes were identified that enriched in the lean and obese modules. Of these, 3956 genes had high k Total ( Supplementary Table S1 ). Moreover, 3292 genes had a MM value > 0.8 and were thus categorized as "hub genes" ( Supplementary Table S1 ). Through this analysis, a total of 1835 genes were identified with high IMC and MM in islets from B6-lean vs. B6-Ob mice ( Supplementary  Table S1 ). This list served as a reference list for the identification of the candidate secreted proteins.
Identification of candidate secreted protein regulators. B6-lean and B6-Ob islet gene expression data
were filtered for secreted proteins based on the differential expression (DE), MM, and IMC ( Fig. 3a) . A total of 2351 transcripts annotated as secreted proteins in the UniProt database were used in the analysis ( Supplementary  Table S2 ). This list was curated based on the presence of a secretory signal sequence in the protein. Using B6-lean and B6-Ob islet expression data, a total of 17939 transcripts were identified to be DE with obesity (false discovery rate, FDR < 5%; Supplementary Table S3 ). Of these, 882 secreted protein transcripts were identified as DE (q < 0.05), and among them, 67 genes had a fold change (FC) > 2.0 in islets ( Supplementary Table S4 ). These transcripts were subsequently filtered for hub genes (MM > 0.8) with high IMC by using the reference list that was identified from the lean and obese enriched modules ( Supplementary Table S1 ). Through these steps, 44 transcripts were identified that encode for secreted proteins that were DE, had high MM with high IMC. This generated a list of candidate regulatory secreted proteins ( Supplementary Table S5 ). A Venn diagram shows the number of genes that were filtered at each step based on the analysis (Fig. 3b ). Cholecystokinin (Cck) and complement 1q-like 3 (C1ql3) were identified to be among the top DE transcripts, with FC of 21.69 and 12.90, respectively (Fig. 3c ). The top 20 secreted protein regulators identified by using this filtering approach are shown in Table 2 . As the role of Cck in islet function has been well characterized [24] [25] [26] [27] , we focused on C1ql3 for downstream analysis. 
Identification of candidate secreted proteins by separately analyzing lean and obese islet expression data.
To determine whether C1ql3 differentially affects islet function in lean vs. obese mice, gene co-expression modules were generated separately for lean and obese mouse islet expression data. A total of 72 modules were identified in islets from lean mice and 78 modules in islets from obese mice ( Fig. 4b ). Of these Module-trait relationships in the islets of lean and obese mice. Each row corresponds to the 28 different color-coded modules identified by WGCNA. The number of genes forming each module are shown in "N Genes . " Cells for the lean and obese phenotype contain the corresponding p-value and correlation coefficient for the module. The color of each cell is assigned based on the correlation value of the module; dark red represents a strong positive correlation and dark blue represents a strong negative correlation. www.nature.com/scientificreports www.nature.com/scientificreports/ modules, 19 in lean ( Fig. 5 and Supplementary Table S6 ) and 17 in obese ( Fig. 6 and Supplementary Table S7 ) were significantly associated with clinical traits (p < 0.05). These modules corresponded with 6394 and 10231 genes in the lean-vs. obese-enriched modules, respectively ( Supplementary Table S8 -S9). Of these, 2021 genes in lean and 1515 genes in obese had high IMC (k Total ) with MM greater than 0.80 (Supplementary Tables S8 and S9, respectively). These lists were further filtered for the 67 secreted protein transcripts that were identified to be DE with FC > 2.0 ( Supplementary Table S4 ). Based on this analysis, 2 secreted protein transcripts, Insl6 and BC017133, were identified as hub genes in islets of lean mice ( Supplementary Table S10 ) and 12 genes as hub genes in islets of obese mice (Table 3 and Supplementary Table S11) ( Fig. 7a ).
Next, we determined secreted protein regulators that might differentially affect islet function in the lean vs. obese state. For this, candidate secreted protein regulators that were identified individually to affect islet function in lean and obese mice ( Table 3 and Supplementary Table S11 ) were compared to 44 secreted protein regulators, which were identified after analyzing merged lean and obese islet gene expression data ( Fig. 7a , Supplementary  Table S5 ). Using a Venn diagram, Insl6 was identified as a regulator of islet function in lean ( Fig. 7d ), while Cck, C1ql3, Serpina7, Creld2, Svop, Smoc1, Tgfβ3, and Serpini1 were identified as regulators of islet function in obese ( Fig. 7b ). Moreover, BC017133 was identified as a regulator of islet function in both lean and obese mice (Fig. 7c ). The ranking of these putative regulators based on FC is shown in Table 4 . C1ql3 was identified as one of the top regulators of islet function specifically in obesity, with an IMC of 2458 and MM of 0.92. Both these attributes were significantly above their respective threshold values for the analysis. Moreover, when the lean and obese samples were analyzed together, the IMC and MM values were 3823.40 and 0.86, respectively, for C1ql3. These results suggest that C1ql3 has high connectivity and likely functions as a hub gene in the regulation of islet function in the obese state.
Gene set enrichment analysis associates C1ql3 with the islet secretory response. Gene set enrichment analysis (GSEA) was performed to predict the cellular function of candidate secreted proteins. The steps used in determining the islet function of C1ql3 are shown in Fig. 8a . Briefly, C1ql3 within-islet correlations www.nature.com/scientificreports www.nature.com/scientificreports/ were determined using lean and obese expression data, and transcripts with a correlation value > |0.5| were selected for the gene ontology (GO) enrichment analysis, generating GO terms. The GO terms containing fewer than 200 genes within a GO term (Bonferroni adjusted p < 0.05) were selected for the identification of cellular pathways affected by C1ql3 (Supplementary Tables S12, S13). Selected GO terms were subjected to REVIGO 28 to generate superclusters, enabling the prediction of C1ql3 function ( Supplementary Table S14 and Fig. 8b ). Each supercluster is represented by a colored rectangle in a tree plot ( Fig. 8b ). 'Regulation of secretion' was identified as a major islet supercluster for C1ql3, comprised predominately of GO terms associated with secretory processes. Smaller superclusters were also identified pertaining to nuclear division, mitotic cell cycle process, and the cellular response to endogenous stimuli (Fig. 8b) . The REVIGO analysis output confirmed C1ql3 correlates primarily with islet secretory function ( Fig. 8 ). To determine the specificity of this analysis in predicting C1ql3 function, GSEA and REVIGO were performed for islet-derived trefoil factor 2 (Tff2) and somatostatin (Sst): Tff2 served as a negative control, as there was no enrichment for the secretory process in islets, while Sst, secreted Modules   NGENES   177  191  244  154  131  376  205  331  565  132  134  255  1265  2262  227  347  161  199  254  262  159  120  681  489  714  1444  507  159  115  276  218  105  292  159  235  206  298  363  134  900  1570  397  206  285  197  113  559  680  118  318  1245  808  170  207  551  272  306  205  121  127  438  5756  1453  244  893  209  108  202  177  249  812  254  302  155 www.nature.com/scientificreports www.nature.com/scientificreports/ from δ-cells and a long-known regulator of islet hormone secretion 29 , served as a positive control ( Supplementary  Fig. S3 ). Moreover, no significant clusters were identified in islets for Ins1 (data not shown). These outcomes suggest that the identification of C1ql3 in a 'regulation of secretion' supercluster was not due to the intrinsic nature of islets as a secretory tissue ( Supplementary Table S15 and Fig. S3a ).
Hierarchical clustering of C1ql3 correlates enriched for secretory processes. Hierarchical www.nature.com/scientificreports www.nature.com/scientificreports/ by gene expression heat maps. Interestingly, many of the C1ql3 correlates that differentiate lean and obese mice were related to the secretory processes ( Fig. 9a) . As a comparison, Figure 9b -c show that the most variable gene expression values were for the correlates associated with secretory terms that clustered in a tree plot into 'regulation of secretion' (enrichment significance: Bonferroni adjusted p < 0.05) and the specific ontology term 'secretion' (enrichment significance: Bonferroni adjusted p < 0.05), respectively. We also clustered the most variably expressed genes across the entire islet gene expression dataset (Fig. 9a) . The similarity between all graphs may indicate that some of the difference may be related to the difference in the factors affecting insulin secretion.
Interestingly, clusters of C1ql3-correlated genes enriched for secretion terms appear to differentiate lean and obese mice. Several genes having disparate roles related to insulin secretion, including Nucb2, Ins2, Cox2, Tcf7l2, and Gcg, were identified across all secreted ontology terms clustered by REVIGO (Fig. 9b ). For the specific ontology term 'secretion' , the genes included Ptprn, Sycn, Sytl4, Lin7c, Vdr, Syt13, Sdf4, Rab11a, Syt9, Pdzd11, Cckar, Nrxn1, Vamp4, Unc13b (Munc13), Snap9, Gcgr, Stxbp5, Syt11, Stxbp2 and Hap1 (Fig. 9c and Supplementary Table S16 ). Among the genes that were most variably expressed across all C1ql3 correlates between lean and obese animals were many of these same genes, as well as Slc2a2 , Klk1, Dmbt1, Rnase1, Rbp4, Itm2c, Med31, ATP6,  PEG3, Ppu, Cpa1, Reg1, Cpb1, Prss2, Ptchd2, and lapp (Fig. 9a) . Many of these genes have previously known roles in regulating metabolic processes related to obesity, diabetes, and specific processes related to insulin secretion. Altogether, these results indicate that in islets, C1ql3 is directly involved or intimately related to pathways associated with secretion and is correlated with genes involved specifically in insulin secretion.
Biological validation identified the role of C1ql3 in regulating insulin secretion. Microarray
expression data for C1ql3 was confirmed by real-time quantitative PCR. An increase in the relative mRNA abundance of C1ql3 was observed in islets of several mouse models of obesity compared to their lean controls. This included greater than 4-fold increase in islets of high-fat-diet-fed obese B6 mice vs. low-fat-diet-fed B6 control mice; ~2.5-fold increase in islets of B6 db/db vs. B6-lean mice, and ~64-fold increase in islets of B6-Ob vs. B6-lean mice ( Fig. 10b-d) . Moreover, a significant increase in C1ql3 protein levels was observed in the islets of B6-Ob vs. B6-lean mice (Fig. 10e) . The increased expression of C1ql3 in islets is correlated with a reduction in glucose-stimulated insulin secretion at 16.7 mM from islets of high-fat-diet-fed obese B6 mice vs. low-fat diet-fed B6 control mice (Fig. 10a) .
Islets are comprised primarily of insulin secreting β-cells, glucagon-secreting α-cells, and somatostatin (SST)-secreting δ-cells. Therefore, we determined the islet cell types that express C1ql3 by immunohistochemistry. Our results show that C1ql3 (green) co-stained with insulin (red) secreting β-cells (Fig. 10f, right panel) . C1ql3 did not co-express with glucagon ( Fig. 10f, left panel) or SST (( Fig. 10f, middle panel) positive cells. We next determined the effect of C1ql3 on insulin secretion. Overexpressing C1ql3 via adenoviral expression in mouse islets decreased insulin secretion as compared to GFP expressing control islets in response to cAMP (3 mM) at 11 mM glucose (a submaximal stimulatory concentration of glucose). C1ql3 had no inhibitory effect on insulin secretion at basal (3 mM) or 11 mM glucose concentrations. We investigated the effect of C1ql3 knockdown on glucose-stimulated insulin secretion (GSIS) from the INS1(832/13) β-cell line. A significant reduction in C1ql3 expression was observed with small interfering (si) RNA targeting of C1ql3 as compared to a scrambled siRNA control (Fig. 10i ). This reduction in C1ql3 expression correlated with increased INS1(832/13) insulin secretion in response to 15 mM glucose (Fig. 10h ). However, knockdown of C1ql3 had no effect on INS1(832/13) insulin secretion at a basal (3 mM) glucose concentration. These results show that C1ql3 is expressed in β-cells and has a direct role in inhibiting insulin secretion.
pathways associated with changes in insulin secretion. Analysis of transcription factors involved in
insulin secretion and islet proliferation. Based on the network analysis, C1ql3 is a potential regulator of islet function, with enriched ontology terms indicating a potential role in insulin secretion processes. To validate this finding, we determined whether C1ql3 regulates the expression of key transcription factors that are involved in islet function that may impact insulin secretion levels. The mRNA abundance of Hnf4α, Hnf1, Egr1, Pdx1, MafA, NeuroD1, Lhx1, and Nkx6.1 was determined in INS1(832/13) β-cells expressing C1ql3 or GFP control. A significant reduction (p < 0.05) in the expression of Pdx1, NeuroD1, MafA, and Nkx61 was observed in response to C1ql3 overexpression. However, the expression of other transcription factors, including Egr1, Hnf4α, Hnf1, and LhX1, remained unaltered in response to C1ql3 (data not shown), suggesting specificity in the C1ql3 effect.
Based on these gene expression results, we determined the effect of C1ql3 on the expression of key β-cell genes such as Gck, Glut2, Kcnj6, and Kcnj11 that are regulated by Pdx1, NeuroD1, MafA, or Nkx6.1. Significant inhibition (p < 0.05) in the expression of Gck, Glut2, and Kcnj6, was observed in C1ql3 compared to control GFP expressing cells (Fig. 10j) . These results suggest that C1ql3 inhibits the expression of transcription factors and their target genes that are key to the pancreatic islet function.
Discussion
Co-expression network analysis along with data filtering approaches of gene expression data obtained from islets of lean and obese mice identified C1ql3 as a hub gene affecting islet function in obesity. Gene set enrichment analysis and hierarchical clustering of C1ql3-correlated transcripts putatively identified C1ql3 as a regulator of secretory processes in islets. Functional validation shows C1ql3 is expressed in β-cells and it inhibits insulin secretion and the mRNA abundance of genes that are important in regulating pancreatic β-cell function. These findings, which are based on an unbiased analysis of lean and obese islet gene expression data and functional characterization identifies C1ql3 as a regulator of islet function in obesity. We posit that alterations in β-cell expression-coupled secretion of C1ql3 regulates insulin secretion in an autocrine and/or paracrine manner.
C1ql3 is a member of the complement-1q/TNF-related (CTRPs) family of secreted proteins [30] [31] [32] . These proteins contain 17 G-X-Y collagen repeats and a conserved C1q domain that are critical for their functional activity. Members of the CTRP family, such as adiponectin 2-4 , C1q/Tnf5 33 , and C1q/Tnf1 34 , are involved in regulating the whole body glucose homeostasis. Fasting or food restriction in mice decreases the expression of C1ql3 in the brain 35 . Conversely, diet-induced obesity (DIO), obesity caused by deficiency in leptin signaling, and agonists of PPARα (a fatty acid-activated transcription factor) increase the mRNA abundance of C1ql3 ~3-fold in the adipose tissue 5 . Elevated C1ql3 levels were reported in the serum of B6-Ob mice as compared to B6-lean 5 , and epidemiology-based studies have associated human C1ql3 serum levels with an elevated risk of T2D 36, 37 . These studies suggest nutritional and/or other changes related to obesity regulate the expression and secretion of C1ql3. Functionally, C1ql3 recombinant protein was reported to have an insulin-sensitizing effect 5, 35 , suggesting a role in affecting glucose metabolism. However, the mechanism by which C1ql3 regulates glucose metabolism by modulating islet function remains uncharacterized.
Islet tissue constitutes less than 1% of the pancreas mass and is a very small tissue in the context of the whole body 38 . Therefore, islet-derived secreted proteins are poised to have an important regulatory function in an autocrine or paracrine manner to affect islet function within the pancreas. Our co-expression network-based analysis identified 18 enriched modules within lean and obese islet expression data. Within these modules, islet-derived candidate secreted proteins were identified and ranked based on their DE, IMC, and MM attributes as potential 'hub genes' (i.e., candidate regulators). 44 candidate secreted proteins were identified based on their high IMC and MM values with FC > 2 (DE, p < 0.05) in islets of lean and obese mice. Furthermore, 2 islet regulators were identified the lean condition and 12 in obesity by separately analyzing lean and obese islet expression data. By comparing regulators that were identified for lean, obese, and merged islet expression data, Cck, C1ql3, Serpina7, Creld2, Svop, Smoc1, Tgfβ3, and Serpini1 were identified to affect islet function in obesity (Table 4 ). These islet-derived regulators are anticipated to mediate, at least in part, the effect of obesity on islet function by either alleviating or exacerbating the ability of islets to compensate for the stress of obesity. Understanding the role of these factors in islet biology will provide insights into obesity-induced T2D.
C1ql3 was identified as one of the top candidates that affect islet function in obesity. This ranking was based on high MM and IMC values of 0.92 and k Total = 2455, respectively, within the islet expression data. The high connectivity of C1ql3 based on these attributes identified C1ql3 as a major "hub gene" affecting islet function in obesity. Ontology enrichment and hierarchical clustering identified C1ql3 to affect secretion processes from islets. Furthermore, C1ql3 is DE (>32-fold) with obesity, and inhibits insulin secretion and the expression of genes involved in β-cell function ( Table 4 and Figs 8 and 10) . These results suggest that islet-derived C1ql3 may contribute to reduced insulin secretion observed during impaired glucose tolerance, even before a clinical diagnosis of T2D.
The correlates of C1ql3 in islets enriched for the GO terms associated with secretion and clustered by the expression levels to differentiate lean vs. obese mice. REVIGO analysis to determine the function of C1ql3 identified 'regulation of secretion' as a major supercluster in islets. This supercluster contained the highest frequency of all the ontology terms identified in islets for C1ql3 correlates. The network of GO terms for this supercluster, determined by PANTHER, corresponded to functions such as cell migration, secretion, organelle localization, regulation of cellular catabolic process, regulation of hormone levels, negative regulation of molecular function, regulation of DNA metabolic process, ion homeostasis, and regulation of secretion. These results are indicative of the role of C1ql3 in regulating secretion from islets. This outcome is also supported by the cluster analysis of C1ql3 correlates identified in islets of lean and obese mice. Many of the C1ql3 correlates that differentiated lean and obese animals were related to β-cell function and have been shown previously to be associated with obesity or T2D ( Fig. 8 and Supplementary Files S12-S14). These genes included Nucb2, Ins2, Cox2, Tcf7l2, Gcg, Ptprn, Sycn, Sytl4, Lin7c, Kcnq5, Unc2 (Munc18), Vdr, Syt13, Sdf4, Hap1, Slc2a2, Klk1, Dmbt1, Rnase1, Rbp4, Itm2c, Med31, Atp6, Peg3, Ppu, Cpa1, Reg1, Cpb1, Prss2, Ptchd2, and lapp [39] [40] [41] [42] [43] . These outcomes support the role of C1ql3 as a regulator of β-cell function that modulates insulin secretion.
Other smaller superclusters identified for C1ql3 in islets were related to the cellular response to endogenous stimulus, nuclear division, mitotic cell process, cell division, and protein phosphorylation. The number of GO terms representing each of these superclusters was lower as compared to the 'regulation of secretion' supercluster. The combined list of ontology terms for these superclusters was associated with organelle fission, nuclear division, negative regulation of programmed cell death, regulation of cell growth, regulation of cell projection organization, mitotic cell cycle, cell cycle phase transition, regulation of cell cycle, chromosome segregation, protein phosphorylation, and cell division (Fig. 8 ). Identification of these cellular functions suggests that the C1ql3 may function in affecting regulating islet mass. This inference is supported by the reduced expression of transcription factors that are key to regulating β-cell mass by C1ql3 (Fig. 10c) .
In screening to determine the mechanism by which C1ql3 regulates islet function, we identified expression of key transcription factors-Pdx1, NeuroD1, Nkx6.1, and MafA-was decreased in response to the overexpression of C1ql3 in pancreatic β-INS1(832/13) cells. These transcription factors function to provide a link between pathways that regulate insulin secretion and pancreatic islet mass in differentiated β-cells and are known to regulate insulin secretion. Islets isolated from Pdx1, MafA, NeuroD1, and Nkx6.1 deficient mice have reduced glucose-stimulated insulin secretion. Additionally, these factors also regulate β-cell growth during the metabolic stress of obesity, pregnancy, and age [44] [45] [46] . Islets from adult mice with 50% reduction in Pdx1 expression were reported to have increased susceptibility to apoptosis, impairment in the ability to maintain β-cell mass with age, and reduction of IGF induced β-cell proliferation. Similarly, deletion of Nkx6.1 in adult mice caused diabetes due to the reduction in insulin secretion and β-cell proliferation. The knockdown of NeuroD1 in adult β-cells caused reversion to immature β-cells. Overexpression of C1ql3 caused a reduction in the expression of Pdx1, NeuroD1, Nkx6.1, and MafA in β-cells (Fig. 10) . These results point to a mechanism by which C1ql3 can modulate both β-cell function and mass by regulating the expression and/or activity of key transcription factors. Delineating the mechanism of action of C1ql3 may identify C1ql3 as a master regulator of β-cell biology. Furthermore, islet cell transcriptional regulation by C1ql3 may provide insights into the mechanism underlying long-term nutritional adaptation of β-cells during obesity and may provide insight into why only a fraction of obese individuals develop T2D. The mechanism by which C1ql3 regulates islet insulin secretion will be the subject of future studies.
The ability of β-cells to adapt to the stress of obesity is critical for the maintenance of whole-body glucose homeostasis and prevention of T2D. Typically, during obesity, fasting glucose levels are increased, which prompts β-cells to increase their mass and insulin secretion to maintain euglycemia. The inability of β-cells to compensate for obesity stress leads to a reduction in functional in β-cell mass, and, ultimately, T2D 13, 47 . Therefore, identification and characterization of regulatory factors that mediate the reduction in functional β-cell mass during obesity will provide critical insights into the mechanisms underlying progression to T2D. C1ql3 is expressed in β-cells, its expression is elevated in islets obtained from mouse models of obesity (HFD-induction, Ob/Ob, and Db/Db), and it inhibits insulin secretion from mouse islets and INS1(832/13) β-cells. These results suggest C1ql3 functions in an autocrine or paracrine manner to negatively regulate insulin secretion from β-cells. Correlation and ontology-based analyses identified C1ql3 as a hub gene with high IMC to affect islet function in obesity by modulating secretion, nuclear division, mitotic cell process, and cell division. These outcomes identified C1ql3 as an important metabolic regulator of islet function that may be involved in modulating both function and mass of β-cells. An important next step will be to determine the role of C1ql3 in balancing β-cell mass and insulin secretion during lean and obese states. These studies are currently being investigated.
In sum, an unbiased data filtering approach identified novel and previously known regulators of islet function in the lean and obese states based on their change in response to obesity (differential expression), magnitude of change (fold change), statistical significance of networks identified by WGCNA (association of modules with obesity), and ranking as regulator/hub genes (module membership). Within this list of candidate gene regulators, genes were additionally filtered based on their overall connectedness to the networks (k Total rank) when using the combined data or lean and obese data separately. This final list of regulators identified known and novel regulators of metabolic processes related to islet function in obesity that would impact the susceptibility to T2D. Importantly, the identification of novel regulators of islet function demonstrates that the gene expression data can be a valuable resource to effectively screen for the novel secreted protein regulators. Our approach could also be used to identify regulators such miRNA, metabolites, natural or synthetic compounds that affect islet function. Identifying such factors that function to contribute towards the disease risk during obesity will be useful in translational medicine as they will improve the risk assessment of the disease state, and their functional characterization will lead to the identification of therapeutic drug targets in obesity.
Materials and Methods
statistical analysis of microarray data. Microarray data from 10-week old lean and obese mice (GEO accession: 10785) was used for analysis in this study 21 . All normalized data (i.e., intensity2 or mlratio) are publicly available for download at the http://diabetes.wisc.edu/search.php website. All results from the differential expression analysis were derived from Keller et al. as identified on the website above 21 . Differentially expressed (DE) genes were selected based on q-values (q < 0.05) ( Supplementary File S3) . Expression levels used for correlation analysis were derived from intensity2 data that was log normalized.
Weighted gene co-expression network analysis. The weighted gene co-expression network analysis
(WGCNA) package in R version 1.63 was used to identify the group of modules representing co-expressed networks of genes in the expression data that was obtained from islets of the lean and obese mice 23 . The determination of the co-expression network was based on first generating a similarity correlation matrix, which was calculated for all the genes in the data by performing a pairwise Pearson's correlation [cor(i, j)]. The similarity matrix was then transformed to an adjacency matrix (AM) (A = [aij] where aij = Sijβ), which is comprised of an unsigned weighted gene co-expression network by using the power β = 6 (soft thresholding) ( Supplementary  Fig. 2 ). The soft threshold function in WGCNA was used to determine the weightiness of the edges connecting the sets of the genes to retrieve stronger results. Soft thresholding establishes the robustness of correlation of genes within a module at a particular power threshold to demonstrate correspondence to scale-free network topology. We identified a soft threshold of β = 6, which was chosen based on the criteria of approximating the scale-free topology of the network 48 , where R 2 = 0.78. Increasing the power via this method to or above the soft-threshold reduces/removes the noise in the correlation network (adjacency matrix), and no sample outliers were identified in the data. To generate a gene dendrogram, the topological overlap matrix (TOM) and dissTOM = (1-TOM) were calculated. Hierarchical clustering based on a Tree cutHeight of 0.2 (based on the dissTOM = (1-TOM)) was used to identify gene clusters within the data. Next, the module eigengene (ME) value was calculated based on the first principal component for the entire expression profile for each module. This analysis was computed using the blockwiseModules function in WGCNA with deepsplit = 3 and minimum module size = 100. Each module was assigned an ID corresponding to a unique color name. The MEs were used in performing module-trait relationship (correlation) analysis and to determine the intramodular connectivity (IMC) and module membership (MM) statistics. The parameters described above were used for generating modules and their MEs, module-trait relationships, MM, and IMC in the lean and obese islet expression data, when analyzed as separately or as merged.
Module-trait relationships.
To determine whether the modules in islets were significantly associated with the lean and obese traits, a binary matrix was generated describing the association of the samples with their respective traits (case (obese) = 1, control (lean) = 0). This matrix was then used as an input file for phenotype traits. The MEs calculated above were used to calculate the p-value (asymptotic) and correlation (calculated using Pearson correlation) value for lean and obese traits. Modules correlated with traits in lean and/or obese islets were filtered based on p < 0.05.
Intramodular connectivity (IMC) and module membership (MM). A connectivity measure (k Total )
was calculated for each candidate regulatory gene by determining the strength of the connection of a gene with the other genes across the enriched modules. Moreover, the k Within was calculated for each gene within their www.nature.com/scientificreports www.nature.com/scientificreports/ overnight with primary antibodies in dilution buffer of 2% BSA in PBS at 4 °C. Anti-C1ql3 antibody (rabbit, 1:500) (Invitrogen, #PA5-75736), anti-insulin antibody (guinea pig, 1:500) (DAKO, #A0564), anti-glucagon antibody (mouse, 1:500) (Sigma, #G2654), and anti-somatostatin antibody (goat, 1:500) (Santa Cruz Biotechnology, #sc-7819) were used for staining. The next day, a secondary antibody was applied to the section for 2 h at room temperature. Anti-Cy5 (rabbit, 1:500) (Jackson ImmunoResearch, #711-175-152), anti-Cy3 (guinea pig 1:500) (Jackson ImmunoResearch, #706-165-148), anti-Cy3 (mouse, 1:500) (Jackson ImmunoResearch Catalog 715-165-161), and anti-Cy3 (goat, 1:500) (Jackson ImmunoResearch, #705-165-003) secondary antibodies were used. Finally, a coverslip was mounted on top of the section using mounting buffer with DAPI and sealed with nail polish. The slides were visualized using an epi-fluorescent microscope at 1376 × 1038-pixel resolution at a total magnification of 25.2. Viewing channels include Cy5 to view C1ql3, Cy3 to view insulin, glucagon, and somatostatin, and DAPI to view the nucleus.
